BP Silver Corp. (TSXV: BPAG) (OTCQB: BPSCF) ("BP Silver" or the "Company") announces that its 2,000 meter ("m") Phase 2 drill ...
Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a ...
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
DeBary's long-planned downtown is moving from vision to reality as years of underground infrastructure work give way to the ...
Local leaders held a grand opening Tuesday for the first phase of the complex, which features 113 units. The next phase will ...
Buy thesis: undervalued despite 700% surge, $193M cash runway to 2029, epilepsy & schizophrenia pipeline catalysts. See more ...
Phase 3 trials of Kailera Therapeutics’ oral GLP-1 prospect have hit their primary endpoints, positioning the biotech’s ...
Supreme Court seeks Centre's response on allowing pregnant IPS probationers to resume training if medically fit.
Goldman Sachs says the HALO trade has worked well this year, but a tougher phase relying on earnings performance lies ahead.
About 1 in 5 women will experience depression and anxiety during pregnancy or in the year after giving birth. If untreated, a ...